Hiroyuki Suzuki

14PUBLICATIONS
17CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiomolecular modelling and designPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 08, 2026
Development of NOTA-based antibody-fragment labeling agent that reduces early renal radioactivity levels.

|Feb 10, 2025
Evaluation of the Gly-Phe-Lys Linker to Reduce the Renal Radioactivity of a [64Cu]Cu-Labeled Multimeric cRGD Peptide.

Zhao-Hui Jin, Mélissa Degardin, Takako Furukawa

|Jan 19, 2025
An 211At-labeled alpha-melanocyte stimulating hormone peptide analog for targeted alpha therapy of metastatic melanoma.

Hiroyuki Suzuki, Saki Yamashita, Shoko Tanaka

|Oct 14, 2024
Investigation of a Radio-Iodinated Alpha-Mangostin for Targeting Estrogen Receptor Alpha (ERα) in Breast Cancer: In Silico Design, Synthesis, and Biological Evaluation.

Muchtaridi Muchtaridi, Wiwit Nurhidayah, Taufik Muhammad Fakih

|Apr 27, 2024
Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies.

Hiroyuki Suzuki, Kento Kannaka, Tomoya Uehara

|Feb 26, 2024
Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics.

Yuta Kaizuka, Hiroyuki Suzuki, Tadashi Watabe

Pageof 3

Frequent Collaborators

10 joint publications

Tomoya Uehara

5 joint publications

Yasushi Arano

3 joint publications

Shigeki Watanabe

3 joint publications

Tadashi Watabe